Theraflu Flu Relief Max Strength Powder
NDC 0067-7922
Product Information
Theraflu Flu Relief Max Strength (acetaminophen, chlorpheniramine maleate, dextromethorphan hbr) is a OTC MONOGRAPH DRUG-approved product labeled by Haleon Us Holdings Llc. This medication is typically used as a histamine h1 receptor antagonists [moa]. It is supplied as a powder for oral administration. This product entry covers the primary NDC 0067-7922 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 0067-7922?
What are the uses of this product?
What are Active Ingredients of this product?
- ACETAMINOPHEN 1000 mg/1 - Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
- CHLORPHENIRAMINE MALEATE 4 mg/1 - A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.
- DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1 - Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (RECEPTORS, N-METHYL-D-ASPARTATE) and acts as a non-competitive channel blocker. It is one of the widely used ANTITUSSIVES, and is also used to study the involvement of glutamate receptors in neurotoxicity.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ACETAMINOPHEN (UNII: 362O9ITL9D)
- ACETAMINOPHEN (UNII: 362O9ITL9D) (Active Moiety)
- DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH)
- DEXTROMETHORPHAN (UNII: 7355X3ROTS) (Active Moiety)
- CHLORPHENIRAMINE MALEATE (UNII: V1Q0O9OJ9Z)
- CHLORPHENIRAMINE (UNII: 3U6IO1965U) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ACESULFAME POTASSIUM (UNII: 23OV73Q5G9)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- ASPARTAME (UNII: Z0H242BBR1)
- D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C RED NO. 40 (UNII: WZB9127XOA)
- MALTODEXTRIN (UNII: 7CVR7L4A2D)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)
- LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
- SUCROSE (UNII: C151H8M554)
- TRIBASIC CALCIUM PHOSPHATE (UNII: 91D9GV0Z28)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2636656 - acetaminophen 1000 MG / dextromethorphan hydrobromide 30 MG Powder for Oral Solution
- RxCUI: 2636656 - acetaminophen 1000 MG / dextromethorphan hydrobromide 30 MG Granules for Oral Solution
- RxCUI: 2636656 - APAP 1000 MG / dextromethorphan hydrobromide 30 MG Powder for Oral Solution
- RxCUI: 2636658 - acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG Powder for Oral Solution
- RxCUI: 2636658 - acetaminophen 1000 MG / chlorpheniramine maleate 4 MG / dextromethorphan hydrobromide 30 MG Powder for Oral Solution
Which are the Pharmacologic Classes of this product?
- Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
- Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
* Please review the full disclaimer at the bottom of this page.